AVEO Stock Falls On Unusually High Volume (AVEO)

NEW YORK ( TheStreet) -- AVEO Pharmaceuticals (Nasdaq: AVEO) is trading at unusually high volume Thursday with 1.4 million shares changing hands. It is currently at four times its average daily volume and trading down 70 cents (-5.6%) at $11.89 as of 10:51 a.m. ET. AVEO has a market cap of $553.4 million and is part of the health care sector and drugs industry. Shares are down 26.8% year to date as of the close of trading on Wednesday. AVEO Pharmaceuticals, Inc., a cancer therapeutics company, engages in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. TheStreet Ratings rates AVEO as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. You can view the full AVEO Ratings Report. See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

null

If you liked this article you might like

How I've Prepared for Hurricane Irma -- and a Market Pullback

How I'm Prepared for Irma -- and a Pullback

AVEO Pharmaceuticals (AVEO) Stock Pops on European Licensing Agreement

When Eyeing Small Biotechs, Partnerships Are Huge

When Eyeing Small Biotechs, Partnerships Are Huge

Exelixis Scores Much-Needed Kidney Cancer Study Win to Boost Drug Sales